Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30350490 | 1.00 | CYP2A6 (0.55) | CYP2A6MAPTALDH1A1HPGDNCEH1 | |
| SCHEMBL3717349 | 0.94 | CYP2A6 (0.63) | CYP2A6MAPTALDH1A1HPGDNCEH1 | |
| SCHEMBL14690638 | 0.90 | MAPT (0.66) | CYP2A6MAPTALDH1A1HPGDNCEH1 | |
| SCHEMBL834744 | 0.87 | CYP2A6 (0.68) | CYP2A6MAPTALDH1A1HPGDMEN1 | |
| SCHEMBL21215857 | 0.82 | CYP2A6 (0.69) | CYP2A6MAPTALDH1A1HPGDMEN1 | |
| SCHEMBL15105728 | 0.82 | CYP2A6 (0.69) | CYP2A6MAPTALDH1A1HPGDMEN1 | |
| SCHEMBL203205 | 0.81 | DHODH (0.55) | CYP2A6MAPTALDH1A1HPGDNCEH1 | |
| SCHEMBL30020656 | 0.81 | DHODH (0.55) | CYP2A6MAPTALDH1A1HPGDNCEH1 | |
| SCHEMBL599006 | 0.80 | CYP2A6 (0.79) | CYP2A6MAPTALDH1A1HPGDMEN1 | |
| SCHEMBL29451111 | 0.80 | CYP2A6 (0.79) | CYP2A6MAPTALDH1A1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519384-B1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | PROMEGA CORP (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20250282723-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-09-11 | — | — | US | disclosed |
| EP-4519384-A1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | Promega Corporation (US) | 2025-03-12 | — | — | EP | disclosed |
| EP-4519385-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION (US) | 2025-03-12 | — | — | EP | disclosed |
| CN-119104641-A | Method for detecting impurities of adapalene starting material by utilizing HPLC method | 湖北广济医药科技有限公司 | 2024-12-10 | — | — | CN | disclosed |
| US-20240191211-A1 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION | 2024-06-13 | — | — | US | disclosed |
| US-20230357266-A1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | PROMEGA CORPORATION | 2023-11-09 | — | — | US | disclosed |
| US-20230357266-A1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | PROMEGA CORPORATION | 2023-11-09 | — | — | US | disclosed |
| US-20230357266-A1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | PROMEGA CORPORATION | 2023-11-09 | — | — | US | disclosed |
| WO-2023215514-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION (US) | 2023-11-09 | — | — | WO | disclosed |
| EP-0194579-B1 | 3-PYRIDYLMETHYLNAPHTHYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-04-03 | — | — | EP | disclosed |
| US-4766127-A | IMBALANCE WITH PROSTACYCLIN; ANTICOAGULANTS | SYNTEX (U.S.A.) INC. (US) | 1988-08-23 | — | — | US | disclosed |
| US-4734406-A | 3-pyridylmethylnaphthyl derivatives and composition containing them useful to inhibit thromboxane synthetase | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-03-29 | — | — | US | disclosed |
| EP-0194579-A2 | 3-Pyridylmethylnaphthyl derivatives, process for their preparation and their use as medicaments | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-09-17 | — | — | EP | disclosed |
| EP-0137010-A4 | NAPHTHYL OR TETRAHYDRONAPHTHYL-SUBSTITUTED NAPHTHOIC ACID AND DE RIVATES. | STANFORD RES INST INT (US) | 1985-08-12 | — | — | EP | disclosed |
| EP-0137010-A1 | NAPHTHYL OR TETRAHYDRONAPHTHYL-SUBSTITUTED NAPHTHOIC ACID AND DE RIVATES | SRI INTERNATIONAL (US) | 1985-04-17 | — | — | EP | disclosed |
| WO-1984003505-A1 | NAPHTHYL OR TETRAHYDRONAPHTHYL-SUBSTITUTED NAPHTHOIC ACID AND DE RIVATES | STANFORD RES INST INT (US) | 1984-09-13 | — | — | WO | disclosed |
| US-4454341-A | ANTITUMOR, SKIN DISORDERS | SRI INTERNATIONAL (US) | 1984-06-12 | — | — | US | disclosed |
| US-4447452-A | ANTIDIABETIC AGENT | AYERST, MCKENNA & HARRISON INC. (CA) | 1984-05-08 | — | — | US | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357266-A1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | BTD, HLCS, TYR | CYP2A6 626/4885MAPT 2176/4885ALDH1A1 268/4885 |
| US-20250282723-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | CRYAA, IAPP, APP | CYP2A6 4681/4885MAPT 21/4885ALDH1A1 4174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.